Published in J Viral Hepat on January 01, 2002
Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients. Gut (2005) 0.86
Pathological evolution of hepatitis C virus-"Healthy carriers". World J Gastroenterol (2008) 0.80
Prognostic factors for progression of liver structural lesions in chronic hepatitis C patients. World J Gastroenterol (2008) 0.79
HCV genotype 2 as a risk factor for reactivation of chronic HCV infection. Gut (2005) 0.78
The impact of antiviral therapy and the influence of metabolic cofactors on the outcome of chronic HCV infection. Int J Hepatol (2011) 0.75
Treatment of chronic hepatitis C in a patient affected by systemic sclerosis. Gastroenterol Res Pract (2009) 0.75
Acute exacerbation of hepatitis in a boy with chronic HCV genotype-2 infection after a 9-year period of normal transaminases levels. Eur J Pediatr (2006) 0.75
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med (1991) 5.69
Transmission of non-A, non-B hepatitis by heat-treated factor VIII concentrate. Lancet (1985) 3.53
Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet (1989) 3.42
Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group. Ann Intern Med (1994) 2.55
Cloning of the gene coding for human L apoferritin. Nucleic Acids Res (1986) 2.31
Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med (1983) 2.16
Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol (2004) 2.02
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Structure of gene and pseudogenes of human apoferritin H. Nucleic Acids Res (1986) 1.91
The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med (1993) 1.79
Sympathetic activation in obese normotensive subjects. Hypertension (1995) 1.78
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis (2005) 1.69
Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation (1998) 1.60
Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur J Endocrinol (1995) 1.58
Differential effects of various Ca2+ antagonists. Gen Pharmacol (1991) 1.53
Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age. Am Heart J (2001) 1.53
Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension (1998) 1.51
Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation. Aliment Pharmacol Ther (2011) 1.49
Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet (1993) 1.47
High prevalence of silent gallstone disease in dialysis patients. Nephron (1994) 1.45
Control of protein traffic between distinct plasma membrane domains. Requirement for a novel 108,000 protein in the fusion of transcytotic vesicles with the apical plasma membrane. J Biol Chem (1993) 1.44
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group. Ann Intern Med (1990) 1.44
Antibody to hepatitis C virus after a vapour-heated factor VIII concentrate. The Study Group of the Fondazione dell'Emofilia. Thromb Haemost (1990) 1.42
High prevalence but low pathogenicity of hepatitis G virus infection in Italian patients with genetic haemochromatosis. Ital J Gastroenterol Hepatol (1998) 1.42
Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis (2003) 1.42
Proliferating cell nuclear antigen assessed by a computer-assisted image analysis system in patients with chronic viral hepatitis and cirrhosis. Dig Liver Dis (2002) 1.39
Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay. J Virol Methods (1998) 1.36
The use of bone-graft substitutes in large bone defects: any specific needs? Injury (2011) 1.35
Asymptomatic liver disease in haemophiliacs. J Clin Pathol (1975) 1.26
Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology (1999) 1.23
The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood (1992) 1.22
Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. Gastroenterology (1983) 1.21
Bacterial communities and enzyme activities of PAHs polluted soils. Chemosphere (2004) 1.21
Neural ensemble coding in inferior temporal cortex. J Neurophysiol (1994) 1.18
Extent and limits of the matching concept in monkeys (Cebus apella). J Exp Psychol Anim Behav Process (1985) 1.17
A comparison of visual and auditory short-term memory in monkeys (Cebus apella). Q J Exp Psychol B (1986) 1.11
Detection of hepatitis B virus DNA in formalin-fixed, paraffin-embedded liver tissue by the polymerase chain reaction. Am J Pathol (1990) 1.11
Ulcerated hemangiomas: clinical characteristics and response to therapy. J Am Acad Dermatol (2001) 1.11
High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology (2001) 1.10
Immune response to hepatitis B virus in children with papular acrodermatitis. Gastroenterology (1977) 1.08
In situ characterization by monoclonal antibodies of the mononuclear cell infiltrate in chronic active hepatitis. Gastroenterology (1983) 1.06
Vibrio cholerae in the horn of Africa: epidemiology, plasmids, tetracycline resistance gene amplification, and comparison between O1 and non-O1 strains. Am J Trop Med Hyg (1995) 1.06
The glycosaminoglycans of the human artery and their changes in atherosclerosis. J Clin Invest (1976) 1.06
A first comparative map of copy number variations in the sheep genome. Genomics (2010) 1.06
Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. Gastroenterology (1996) 1.06
Representation of serial order in monkeys (Cebus apella). J Exp Psychol Anim Behav Process (1988) 1.05
Efficacy of double intrauterine insemination in controlled ovarian hyperstimulation cycles. Fertil Steril (1999) 1.04
The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors. Hepatology (1997) 1.03
T and B lymphocytes in patients with chronic active hepatitis (CAH). Clin Exp Immunol (1977) 1.03
Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs. Arch Intern Med (1989) 1.02
A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. Hepatology (1997) 1.02
A clinicopathological study of liver disease in haemophiliacs. J Clin Pathol (1978) 1.02
[Hybrid composites: evolution and analysis]. Attual Dent (1988) 1.01
High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. Hepatology (1999) 1.00
Tibial pilon fractures: which method of treatment? Injury (2010) 1.00
Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation. Gut (2008) 1.00
Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol (1998) 0.99
Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. Gastroenterology (1988) 0.99
Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1. Leukemia (2013) 0.98
Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin. Aliment Pharmacol Ther (2012) 0.97
Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J Viral Hepat (2000) 0.97
Idiopathic haemochromatosis and HLA antigens in Italy: is A3 Bw35 HLA haplotype a marker for idiopathic haemochromatosis gene in north east regions? J Clin Pathol (1986) 0.97
Fluctuations of radial artery distensibility throughout the menstrual cycle. Arterioscler Thromb Vasc Biol (1999) 0.97
Serial learning with wild card items by monkeys (Cebus apella): implications for knowledge of ordinal position. J Comp Psychol (1989) 0.96
Synthesis and anticonvulsant activity of a new class of 2-[(arylalky)amino]alkanamide derivatives. J Med Chem (1998) 0.95
A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines. Leukemia (2008) 0.95
Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy. J Viral Hepat (2013) 0.95
Identification of a novel molecular partner of the E2A gene in childhood leukemia. Leukemia (1999) 0.95
A new method for identification of Trichomonas vaginalis by fluorescent DNA in situ hybridization. J Clin Microbiol (1994) 0.95
Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J Hepatol (1996) 0.94
A genome-wide admixture scan for ancestry-linked genes predisposing to sarcoidosis in African-Americans. Genes Immun (2010) 0.94
High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol (2003) 0.94
A survey of the necessity of the hospitalization day in an Italian teaching hospital. Qual Assur Health Care (1991) 0.94
Antihyperglycemic and blood pressure-reducing effects of stevioside in the diabetic Goto-Kakizaki rat. Metabolism (2003) 0.93
High prevalence of TT virus (TTV) in naive chimpanzees and in hepatitis C virus-infected humans: frequent mixed infections and identification of new TTV genotypes in chimpanzees. J Gen Virol (2000) 0.93
Diversity of antinuclear antibody responses in hepatocellular carcinoma. J Hepatol (1997) 0.93
Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT. Bone Marrow Transplant (2010) 0.93
Pathogenetic and clinical aspects of C1 inhibitor deficiency. Immunobiology (1998) 0.93
Lipoproteins in human atherosclerotic vessels. I. Biochemical properties of arterial low density lipoproteins, very low density lipoproteins, and high density lipoproteins. Exp Mol Pathol (1979) 0.93
Effects of anticalcifying and antifibrobrotic drugs on pre-established atherosclerosis in the rabbit. Atherosclerosis (1979) 0.92
Identification and association analysis of several hundred single nucleotide polymorphisms within candidate genes for back fat thickness in Italian Large White pigs using a selective genotyping approach. J Anim Sci (2012) 0.92
Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma. J Viral Hepat (2007) 0.92